- Home
- ALZN vs ELWS Comparison
ALZN vs ELWS Comparison
Compare ALZN & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- ELWS
- Stock Information
- Founded
- ALZN 2016
- ELWS 2018
- Country
- ALZN United States
- ELWS Japan
- Employees
- ALZN N/A
- ELWS N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- ELWS
- Sector
- ALZN Health Care
- ELWS
- Exchange
- ALZN Nasdaq
- ELWS Nasdaq
- Market Cap
- ALZN 6.9M
- ELWS 6.3M
- IPO Year
- ALZN 2021
- ELWS 2023
- Fundamental
- Price
- ALZN $1.66
- ELWS $2.19
- Analyst Decision
- ALZN
- ELWS
- Analyst Count
- ALZN 0
- ELWS 0
- Target Price
- ALZN N/A
- ELWS N/A
- AVG Volume (30 Days)
- ALZN 271.9K
- ELWS 14.8K
- Earning Date
- ALZN 09-11-2024
- ELWS 11-11-2024
- Dividend Yield
- ALZN N/A
- ELWS N/A
- EPS Growth
- ALZN N/A
- ELWS N/A
- EPS
- ALZN N/A
- ELWS N/A
- Revenue
- ALZN N/A
- ELWS $1,139,113.00
- Revenue This Year
- ALZN N/A
- ELWS N/A
- Revenue Next Year
- ALZN N/A
- ELWS N/A
- P/E Ratio
- ALZN N/A
- ELWS N/A
- Revenue Growth
- ALZN N/A
- ELWS 285.14
- 52 Week Low
- ALZN $1.40
- ELWS $1.04
- 52 Week High
- ALZN $34.50
- ELWS $13.00
- Technical
- Relative Strength Index (RSI)
- ALZN 39.08
- ELWS 44.81
- Support Level
- ALZN $1.55
- ELWS $2.16
- Resistance Level
- ALZN $1.68
- ELWS $2.49
- Average True Range (ATR)
- ALZN 0.14
- ELWS 0.19
- MACD
- ALZN 0.05
- ELWS 0.00
- Stochastic Oscillator
- ALZN 60.47
- ELWS 19.25
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.